Metastatic Castration Resistant Prostate Cancer

• START Los Angeles — Los Angeles, California, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• START Midwest — Grand Rapids, Michigan, United States
• START New Jersey — East Brunswick, New Jersey, United States

• Urology Specialists of the Carolinas - University Place — Charlotte, North Carolina, United States
• Summit Urology — Murray, Utah, United States

• Novartis Investigative Site — Konstanz, Baden-Wurttemberg, Germany
• Novartis Investigative Site — Stuttgart, Baden-Wurttemberg, Germany
• Novartis Investigative Site — Munich, Bavaria, Germany
• Novartis Investigative Site — Regensburg, Bavaria, Germany

• Novartis Investigative Site — Alessandria, AL, Italy
• Novartis Investigative Site — Asti, AT, Italy
• Novartis Investigative Site — Bergamo, BG, Italy
• Novartis Investigative Site — Brescia, BS, Italy

• Arizona Urology Specialists — Tucson, Arizona, United States
• Los Angeles Cancer Network — Anaheim, California, United States
• Providence Medical Group Oncology Santa Rosa — Santa Rosa, California, United States
• Florida Urology Partners — Tampa, Florida, United States

• GenesisCare North Shore (Oncology) — Sydney, New South Wales, Australia
• Sydney Adventist Hospital — Sydney, New South Wales, Australia
• Cancer Research SA — Adelaide, South Australia, Australia
• Southern Oncology Clinical Research Unit — Adelaide, South Australia, Australia

• National Institutes of Health Clinical Center — Bethesda, Maryland, United States

Not specified

• Site IN00002 — Ahmedabad, India
• Site IN00004 — Hubli, India
• Site IN00008 — Kolkata, India
• Site IN00003 — Nashik, India

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Mayo Clinic - Arizona — Phoenix, Arizona, United States
• Arizona Oncology Associates - USOR — Tucson, Arizona, United States
• University of Southern California — Beverly Hills, California, United States